These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 10731757)
1. [Adverse (cardio-)vascular effects of vinorelbine in non-small-cell bronchial carcinoma]. Kirschner J; Kolb M; Müller J; Jacobi I Pneumologie; 2000 Feb; 54(2):54-7. PubMed ID: 10731757 [TBL] [Abstract][Full Text] [Related]
2. Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report. Zerna C; Guenther M; Folprecht G; Puetz V J Chemother; 2017 Feb; 29(1):49-53. PubMed ID: 25579322 [TBL] [Abstract][Full Text] [Related]
3. [Non-small-cell bronchial cancers: long-term survival after single drug chemotherapy with vinorelbine]. Julien S; Jacoulet P; Dubiez A; Westeel V; Depierre A Rev Pneumol Clin; 1999 Sep; 55(4):205-10. PubMed ID: 10573748 [TBL] [Abstract][Full Text] [Related]
4. Respiratory failure following vinorelbine tartrate infusion in a patient with non-small cell lung cancer. Kouroukis C; Hings I Chest; 1997 Sep; 112(3):846-8. PubMed ID: 9315826 [TBL] [Abstract][Full Text] [Related]
5. Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine. Liebmann J; Friedman K Am J Med; 1996 Dec; 101(6):658-9. PubMed ID: 9003116 [No Abstract] [Full Text] [Related]
6. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study]. Nakayama S; Matsubara N; Sakai T; Aso N Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554 [No Abstract] [Full Text] [Related]
7. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
8. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Chang AY; DeVore R; Johnson D Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231 [TBL] [Abstract][Full Text] [Related]
9. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study. Carabante-Ocón F; Cobo-Dols M; Benavides-Orgaz M; Gil-Calle S; Alés-Díaz I; Bretón-García JJ; Villar-Chamorro E; Montesa-Pino A; Alcalde-García J; Gutiérrez-Calderón V Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099 [TBL] [Abstract][Full Text] [Related]
10. Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC. Mencoboni M; Filiberti RA; Taveggia P; Del Corso L; Del Conte A; Covesnon MG; Puccetti C; Donati S; Auriati L; Amoroso D; Camerini A Anticancer Res; 2017 Jun; 37(6):3189-3194. PubMed ID: 28551663 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
12. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer. Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A; J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075 [TBL] [Abstract][Full Text] [Related]
13. [Myocardial infarction and vinorelbine. Report of a case]. Dubos C; Prévost JN; Brun J; Rousselot P Rev Mal Respir; 1991; 8(3):299-300. PubMed ID: 1857829 [TBL] [Abstract][Full Text] [Related]
14. Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study. Adam Z; Coupková H; Kolek V; Kucera M; Loffelmann L; Martinez A; Nováková M; Průsa P; Reiterer P; Skalová B Acta Med Austriaca; 1995; 22(5):120-4. PubMed ID: 8651041 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339 [TBL] [Abstract][Full Text] [Related]
16. Skin necrosis from extravasation of vinorelbine. Moreno de Vega MJ; Dauden E; Abajo P; Bartolome B; Fraga J; Garcia-Diez A J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):488-90. PubMed ID: 12428844 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer. Hillner BE; Smith TJ Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group. Kontopodis E; Hatzidaki D; Varthalitis I; Kentepozidis N; Giassas S; Pantazopoulos N; Vardakis N; Rovithi M; Georgoulias V; Agelaki S J Chemother; 2013 Feb; 25(1):49-55. PubMed ID: 23433445 [TBL] [Abstract][Full Text] [Related]